2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Gary M Brittenham, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vitamin D for Sickle-cell Respiratory Complications Experimental: Vitamin D3 100,000 IU, Active Comparator: Vitamin D3 12,000 IU - Sickle Cell Disease, Vitamin D Deficiency | Phase 2 | Completed | Gary M Brittenham, MD | 70 | 2011-12-13 | 2024-08-09 |
| Study of Vitamin D in Children With Sickle Cell Disease Vitamin D3 - Sickle Cell Disease | Phase 1 / Phase 2 | Completed | Gary M Brittenham, MD | 4 | 2011-01-01 | 2023-04-12 |
Anemia, Sickle Cell (2) · Acute Chest Syndrome (1) · Asthma (1) · Respiratory Tract Infections (1) · Vitamin D Deficiency (1)
Cholecalciferol (2) · Vitamin D (1)
United States (2)
Gary Brittenham, MD (1) · Margaret T Lee, MD (1) · Margaret T. Lee, MD (1)